E. R. Chulie Ulloa
We investigate novel therapeutic strategies (e.g., immune-based therapies and drug-repurposing) to treat drug-tolerant or -resistant bacterial pathogens.
We investigate novel therapeutic strategies (e.g., immune-based therapies and drug-repurposing) to treat drug-tolerant or -resistant bacterial pathogens.
Understanding the Redox homeostasis of Toxoplasma gondii to find new therapeutic targets
Our laboratory studies the mechanism and regulation of mRNA processing in development and in pathogen-host interactions.
The Downing Lab explores new and innovative approaches to cell and tissue engineering. We are particularly interested in understanding how
Infectious Disease and Bacterial Pathogenesis Research on the intracellular bacterium Chlamydia: focus on gene regulation, host-pathogen interactions
High-throughput genetics, evolution of Salmonella pathogenesis; bacterial therapy for cancer; cancer genomics and prognostic